Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN320133 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1) antibody (PE)
- Antibody type
- Monoclonal
- Description
- Affinity chromatography on Protein G
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- NKTA255
- Vial size
- 25 tests
- Storage
- Prior to and following reconstitution store at 2-8°C. DO NOT FREEZE.
- Handling
- This product is photosensitive and should be protected from light
Submitted references Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells.
Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias.
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
Zocchi MR, Pellegatta F, Pierri I, Gobbi M, Poggi A
European journal of immunology 2001 Dec;31(12):3667-75
European journal of immunology 2001 Dec;31(12):3667-75
Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias.
Poggi A, Pellegatta F, Leone BE, Moretta L, Zocchi MR
European journal of immunology 2000 Oct;30(10):2751-8
European journal of immunology 2000 Oct;30(10):2751-8
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A
European journal of immunology 1995 Feb;25(2):369-76
European journal of immunology 1995 Feb;25(2):369-76
No comments: Submit comment
No validations: Submit validation data